209 related articles for article (PubMed ID: 22459152)
1. The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes.
Tota B; Gentile S; Pasqua T; Bassino E; Koshimizu H; Cawley NX; Cerra MC; Loh YP; Angelone T
FASEB J; 2012 Jul; 26(7):2888-98. PubMed ID: 22459152
[TBL] [Abstract][Full Text] [Related]
2. Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death.
Koshimizu H; Cawley NX; Yergy AL; Loh YP
J Mol Neurosci; 2011 Oct; 45(2):294-303. PubMed ID: 21537909
[TBL] [Abstract][Full Text] [Related]
3. Serpinins: role in granule biogenesis, inhibition of cell death and cardiac function.
Loh YP; Koshimizu H; Cawley NX; Tota B
Curr Med Chem; 2012; 19(24):4086-92. PubMed ID: 22834799
[TBL] [Abstract][Full Text] [Related]
4. pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury.
Pasqua T; Tota B; Penna C; Corti A; Cerra MC; Loh Y P; Angelone T
J Endocrinol; 2015 Dec; 227(3):167-178. PubMed ID: 26400960
[TBL] [Abstract][Full Text] [Related]
5. The Chromogranin A-derived sympathomimetic serpinin depresses myocardial performance in teleost and amphibian hearts.
Imbrogno S; Mazza R; Pugliese C; Filice M; Angelone T; Loh YP; Tota B; Cerra MC
Gen Comp Endocrinol; 2017 Jan; 240():1-9. PubMed ID: 27633326
[TBL] [Abstract][Full Text] [Related]
6. Serpinin: a novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells.
Koshimizu H; Cawley NX; Kim T; Yergey AL; Loh YP
Mol Endocrinol; 2011 May; 25(5):732-44. PubMed ID: 21436258
[TBL] [Abstract][Full Text] [Related]
7. The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide.
Cerra MC; Gallo MP; Angelone T; Quintieri AM; Pulerà E; Filice E; Guérold B; Shooshtarizadeh P; Levi R; Ramella R; Brero A; Boero O; Metz-Boutigue MH; Tota B; Alloatti G
FASEB J; 2008 Nov; 22(11):3992-4004. PubMed ID: 18697842
[TBL] [Abstract][Full Text] [Related]
8. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.
Angelone T; Quintieri AM; Brar BK; Limchaiyawat PT; Tota B; Mahata SK; Cerra MC
Endocrinology; 2008 Oct; 149(10):4780-93. PubMed ID: 18535098
[TBL] [Abstract][Full Text] [Related]
9. Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts.
Pasqua T; Corti A; Gentile S; Pochini L; Bianco M; Metz-Boutigue MH; Cerra MC; Tota B; Angelone T
Endocrinology; 2013 Sep; 154(9):3353-65. PubMed ID: 23751870
[TBL] [Abstract][Full Text] [Related]
10. Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart.
Mazza R; Gattuso A; Mannarino C; Brar BK; Barbieri SF; Tota B; Mahata SK
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H113-22. PubMed ID: 18469147
[TBL] [Abstract][Full Text] [Related]
11. The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish.
Imbrogno S; Garofalo F; Cerra MC; Mahata SK; Tota B
J Exp Biol; 2010 Nov; 213(Pt 21):3636-43. PubMed ID: 20952611
[TBL] [Abstract][Full Text] [Related]
12. Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.
Tota B; Mazza R; Angelone T; Nullans G; Metz-Boutigue MH; Aunis D; Helle KB
Regul Pept; 2003 Jul; 114(2-3):123-30. PubMed ID: 12832100
[TBL] [Abstract][Full Text] [Related]
13. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart.
Cerra MC; De Iuri L; Angelone T; Corti A; Tota B
Basic Res Cardiol; 2006 Jan; 101(1):43-52. PubMed ID: 16151967
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium.
Gallo MP; Levi R; Ramella R; Brero A; Boero O; Tota B; Alloatti G
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2906-12. PubMed ID: 17293489
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection against ischemia/reperfusion injury and chromogranin A-derived peptides.
Penna C; Tullio F; Perrelli MG; Mancardi D; Pagliaro P
Curr Med Chem; 2012; 19(24):4074-85. PubMed ID: 22834798
[TBL] [Abstract][Full Text] [Related]
16. Characterization of natural vasostatin-containing peptides in rat heart.
Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA₁₋₆₄) in the rat heart.
Angelone T; Quintieri AM; Goumon Y; Di Felice V; Filice E; Gattuso A; Mazza R; Corti A; Tota B; Metz-Boutigue MH; Cerra MC
Regul Pept; 2010 Nov; 165(1):78-85. PubMed ID: 19896507
[TBL] [Abstract][Full Text] [Related]
18. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
19. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
Mahata SK; Corti A
Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]